REDHILL BIOPHARMA LTD-SP ADR (RDHL)

US7574682024 - ADR

0.4155  0 (-1.05%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
6.53M61.80M85.76M64.36M6.29M
Cost Of Goods
3.46M33.34M40.51M36.09M2.26M
Gross Profit
3.07M28.46M45.25M28.27M4.03M
Operating Expenses
-9.56M71.30M117.48M91.15M47.23M
Research and Development
3.53M7.28M29.50M16.49M17.42M
Selling, General, and Administrative Expenses
30.98M64.03M87.99M74.66M29.81M
Operating Income
12.63M-42.84M-72.24M-62.88M-43.20M
Interest Income/Expense
-7.48M-28.83M-16.61M-12.58M420.00K
Other Income/Expense
-1.82M0.000.0090.00K470.00K
Non Recurring Items
20.59MN/A-8.90M-800.00KN/A
Income Before Taxes
23.92M-71.67M-97.74M-76.17M-42.30M
Income Tax
N/AN/AN/AN/AN/A
Net Income
23.92M-71.67M-97.74M-76.17M-42.30M
EBITDA
14.62M-34.68M-54.09M-54.13M-41.98M
 
Per Share Data
EPS Diluted Total Ops
0.75-9.76-17.08-17.08-11.38
Non GAAP EPS
N/AN/A-64.50-2.10-1.45
 
Statistics
Gross Profit Margin
47.03%46.05%52.76%43.92%64.07%
Profit Margin
366.25%-115.97%-113.97%-118.35%-672.50%
Operating Profit Margin
193.45%-69.32%-84.24%-97.70%-686.80%

All data in USD

Charts